Related Experiment Video
Updated: May 18, 2026

11:54
Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
Hydatidiform mole: a study of 90 cases
1Department of Obstetrics and Gynaecology, King Fahd Hospital of the University, Al-Khobar, Saudi Arabia.
Journal of Family & Community Medicine
|September 26, 2012
Summary
The incidence of hydatidiform mole (HM) in Saudi Arabia was 2.2 per 1000 deliveries. Early diagnosis and treatment of HM are crucial to reduce complications like hemorrhage and sepsis.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Endocrinology
- Oncology
Background:
- Hydatidiform mole (HM) is a gestational trophoblastic neoplasm.
- Understanding its incidence and complications is vital for patient management.
Purpose of the Study:
- To determine the incidence, epidemiology, complications, and management of hydatidiform mole (HM) at King Fahd Hospital of the University (KFHU), Saudi Arabia.
Main Methods:
- A 15-year retrospective study (May 1983-May 1998) analyzed 90 cases of HM.
- Data collected included maternal characteristics, clinical presentation, tumor behavior, management, and complications.
Main Results:
- The incidence of HM was 2.2 per 1000 deliveries.
- Vaginal bleeding (90%) was the most common symptom; uterine size discrepancies and ovarian enlargement were also noted.
- Complications included hemorrhage (21%) and sepsis (10%), more frequent in late-presenting patients. Invasive mole and choriocarcinoma occurred in 6.7% and 3.3% of cases, respectively.
Conclusions:
- The incidence of HM in this Saudi Arabian cohort is comparable to rates in some Eastern countries.
- Earlier diagnosis and prompt treatment of HM are recommended to decrease complication rates.
Keywords:
Hydatidiform mole (HM) complication